TP53 and KRAS co-mutations are associated with worse outcomes in mucinous ovarian carcinomas. - Zhang Y; Barkdull S; Kontoyiannis PD; Legarreta AF; Gershenson DM; Ramalingam P; Frumovitz MM; Sood AK (Frontiers in oncology, 2025)